» Articles » PMID: 36003910

The Underlying Pathological Mechanism of Ferroptosis in the Development of Cardiovascular Disease

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular diseases (CVDs) have been attracting the attention of academic society for decades. Numerous researchers contributed to figuring out the core mechanisms underlying CVDs. Among those, pathological decompensated cellular loss posed by cell death in different kinds, namely necrosis, apoptosis and necroptosis, was widely regarded to accelerate the pathological development of most heart diseases and deteriorate cardiac function. Recently, apart from programmed cell death revealed previously, ferroptosis, a brand-new cellular death identified by its ferrous-iron-dependent manner, has been demonstrated to govern the occurrence and development of different cardiovascular disorders in many types of research as well. Therefore, clarifying the regulatory function of ferroptosis is conducive to finding out strategies for cardio-protection in different conditions and improving the prognosis of CVDs. Here, molecular mechanisms concerned are summarized systematically and categorized to depict the regulatory network of ferroptosis and point out potential therapeutic targets for diverse cardiovascular disorders.

Citing Articles

MMP9 drives ferroptosis by regulating GPX4 and iron signaling.

Gawargi F, Mishra P iScience. 2024; 27(9):110622.

PMID: 39252956 PMC: 11382059. DOI: 10.1016/j.isci.2024.110622.


Ovaries of estrogen receptor 1-deficient mice show iron overload and signs of aging.

Schroder S, Krizanac M, Kim P, Kessel J, Weiskirchen R Front Endocrinol (Lausanne). 2024; 15:1325386.

PMID: 38464972 PMC: 10920212. DOI: 10.3389/fendo.2024.1325386.


Ferroptosis and its emerging role in kidney stone formation.

Yang J, Wu W, Amier Y, Li X, Wan W, Xun Y Mol Biol Rep. 2024; 51(1):314.

PMID: 38376557 PMC: 10879253. DOI: 10.1007/s11033-024-09259-1.


Noncoding RNAs regulating ferroptosis in cardiovascular diseases: novel roles and therapeutic strategies.

Wu C, Bao S, Sun H, Chen X, Yang L, Li R Mol Cell Biochem. 2023; 479(11):2827-2841.

PMID: 38064139 PMC: 11473578. DOI: 10.1007/s11010-023-04895-w.


The mechanism of ferroptosis and its related diseases.

Feng S, Tang D, Wang Y, Li X, Bao H, Tang C Mol Biomed. 2023; 4(1):33.

PMID: 37840106 PMC: 10577123. DOI: 10.1186/s43556-023-00142-2.

References
1.
Zhou Y, Que K, Zhang Z, Yi Z, Zhao P, You Y . Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl-p53 pathway. Cancer Med. 2018; 7(8):4012-4022. PMC: 6089144. DOI: 10.1002/cam4.1670. View

2.
Dixon S, Lemberg K, Lamprecht M, Skouta R, Zaitsev E, Gleason C . Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012; 149(5):1060-72. PMC: 3367386. DOI: 10.1016/j.cell.2012.03.042. View

3.
Venardos K, Perkins A, Headrick J, Kaye D . Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem. 2007; 14(14):1539-49. DOI: 10.2174/092986707780831078. View

4.
Misslinger M, Lechner B, Bacher K, Haas H . Iron-sensing is governed by mitochondrial, not by cytosolic iron-sulfur cluster biogenesis in Aspergillus fumigatus. Metallomics. 2018; 10(11):1687-1700. PMC: 6250123. DOI: 10.1039/c8mt00263k. View

5.
Pei Z, Liu Y, Liu S, Jin W, Luo Y, Sun M . FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis. Metabolism. 2021; 122:154840. DOI: 10.1016/j.metabol.2021.154840. View